138 related articles for article (PubMed ID: 17524231)
1. Preparation, characterization and pharmacokinetics of N-palmitoyl chitosan anchored docetaxel liposomes.
Liang G; Jia-Bi Z; Fei X; Bin N
J Pharm Pharmacol; 2007 May; 59(5):661-7. PubMed ID: 17524231
[TBL] [Abstract][Full Text] [Related]
2. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.
Qu G; Wu X; Yin L; Zhang C
Biomed Pharmacother; 2012 Feb; 66(1):46-51. PubMed ID: 22264883
[TBL] [Abstract][Full Text] [Related]
3. Solid dispersion and effervescent techniques used to prepare docetaxel liposomes for lung-targeted delivery system: in vitro and in vivo evaluation.
Zhao L; Wei Y; Li W; Liu Y; Wang Y; Zhong X; Yu Y
J Drug Target; 2011 Apr; 19(3):171-8. PubMed ID: 20429774
[TBL] [Abstract][Full Text] [Related]
4. Stability and pharmacokinetic studies of O-palmitoyl amylopectin anchored dipyridamole liposomes.
Cheng J; Zhu JB; Wen N; Xiong F
Int J Pharm; 2006 Apr; 313(1-2):136-43. PubMed ID: 16540271
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of docetaxel liposomes and their pharmacokinetics in rabbits].
Huang HB; Liu T; Lin ZC; Zhong JT; Lin PL; Liu JY; Tan YY; Li S; Liao H; Xu YH
Ai Zheng; 2007 Dec; 26(12):1287-91. PubMed ID: 18076788
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
[TBL] [Abstract][Full Text] [Related]
8. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
Li J; Xu H; Ke X; Tian J
J Drug Target; 2012 Jun; 20(5):467-73. PubMed ID: 22577855
[TBL] [Abstract][Full Text] [Related]
9. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and evaluation of docetaxel-loaded, folate-conjugated PEG-liposomes.
Yuan Z; Chen D; Zhang S; Zheng Z
Yakugaku Zasshi; 2010 Oct; 130(10):1353-9. PubMed ID: 20930488
[TBL] [Abstract][Full Text] [Related]
11. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals.
Li X; Du L; Wang C; Liu Y; Mei X; Jin Y
Pharmazie; 2011 Jul; 66(7):479-83. PubMed ID: 21812321
[TBL] [Abstract][Full Text] [Related]
13. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
14. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
[TBL] [Abstract][Full Text] [Related]
15. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
16. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Wu J; Shen Q; Fang L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
[TBL] [Abstract][Full Text] [Related]
17. Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats.
Lee JH; Oh JH; Lee YJ
Xenobiotica; 2011 Sep; 41(9):797-804. PubMed ID: 21561320
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
Zhai G; Wu J; Xiang G; Mao W; Yu B; Li H; Piao L; Lee LJ; Lee RJ
J Nanosci Nanotechnol; 2009 Mar; 9(3):2155-61. PubMed ID: 19435095
[TBL] [Abstract][Full Text] [Related]
19. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.
Wang J; Huang G
Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976
[TBL] [Abstract][Full Text] [Related]
20. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
